The coding region for the structural and nonstructural polypeptides of the type A12 foot-and-mouth disease virus genome has been identified by nucleotide sequencing of cloned DNA derived from the viral RNA. In addition, 704 nucleotides in the 5' untranslated region between the polycytidylic acid tract and the probable initiation codon of the first translated gene, P16-L, have been sequenced. This region has several potential initiation codons, one of which appears to be a low-frequency alternate initiation site. The coding region encompasses 6,912 nucleotides and ends in a single termination codon, UAA, located 96 nucleotides upstream from a 3'-terminal polyadenylic acid tract. Microsequencing of radiolabeled in vivo and in vitro translation products identified the genome position of the major foot-and-mouth disease virus proteins and the cleavage sites recognized by the putative viral protease and an additional protease(s), probably of cellular origin, to generate primary and functional foot-and-mouth disease virus polypeptides.
The genome of foot-and-mouth disease virus (FMDV), an aphthovirus of the picornavirus family, is a single-stranded RNA molecule that acts directly as an mRNA. It contains a covalently bound polypeptide, VPg, at its 5' end (14, 40) and a 100-to 150-base polycytidylic acid sequence about 300 nucleotides from the 5' end (4, 19, 37) and terminates in a polyadenylic acid tract approximately 40 residues long (7). The RNA codes for a single polyprotein of about 250,000 daltons, which is subsequently cleaved by cellular and viral proteases to yield viral structural and nonstructural polypeptides (9, 15) .
Four primary genome products result from initial protease cleavage of the 250-kilodalton polyprotein. These products are used to define the four functional genome regions (Table  1) and are similar to those delineated by Kitamura et al. (21) for the poliovirus genome and by Palmenberg et al. (32) for the encephalomyocarditis virus genome. For FMDV, these four regions are as follows: an L region, 5' to the capsid components, that codes for a leader polypeptide (P16-L); a P1 region encoding the precursor for capsid polypeptides (P91); a P2 region coding for the precursor (P56) of polypeptides in the middle genome region; and a P3 region that encodes the precursor (P102), which includes the three VPg molecules (12) , a putative viral protease (15, 23) , and the viral RNA polymerase (9, 36) . The polypeptides described in this manuscript are identified by their molecular weights as determined by polyacrylamide gel electrophoresis followed by map coordinates (38) .
The nucleotide sequences of the P1 region and the derived amino acid sequence of the polypeptides have been published previously (5, 22, 25, 27, 47) , and the cleavage sites that are involved in the processing of the mature P1 polypeptides have been identified from published amino acid sequences (1, 28, 46) . Recently the nucleotide sequence of the entire open reading frame for A10 and the L and P1 regions and a portion of the P2 region of Cl FMDV have been published (3, 6) . In the present communication, nucleotide-derived amino acid sequences of the entire open reading frame are presented for FMDV type A12 and compared with radiolabeled amino acid microsequencing results to map the positions of the translation-initiation codon and the nonstructural polypeptides encoded in the L, P2, and P3 regions. The peptide bonds cleaved to generate the major FMDV polypeptides have been identified, and their positions have been mapped on the genome.
MATERIALS AND METHODS
Virus growth, purification, and RNA isolation. A largeplaque ab variant of FMDV type A12 strain 119 was grown and purified as previously described (2, 8, 48) . Viral RNA was extracted and purified by the method of Grubman et al. (16) and used as template in reverse transcription.
cDNA synthesis and cloning. cDNA molecules were synthesized by using reverse transcriptase and three types of primers: oligodeoxythymidylic acid, calf thymus DNA, and oligonucleotide primers synthesized to prime at specific regions of the genome. Double-stranded DNA transcripts were inserted into the PstI site of the Escherichia coli plasmid pBR322 with oligodeoxycytidylic acid-oligodeoxyguanidylic acid tails and cloned as previously described (13, 22, 49) .
Restriction endonuclease analysis. Restriction endonucleases were purchased from Bethesda Research Laboratories (Bethesda, Md.) and New England Biolabs (Waltham, Mass.). The sizes of the DNA cleavage products were determined by polyacrylamide gel electrophoresis and agarose electrophoresis with various pBR322 cleavage fragments as molecular weight markers.
DNA sequencing. Restriction fragments from the various 
Glu/Ser-Gly P18-3C
Glu/Gly P61-3DPOL (C terminus) "Polypeptides of unknown function are designated by molecular weight as determined by polyacrylamide gel electrophoresis followed by the genome region in which they are located (1, 2, and 3) and then followed by the relative location within that genome region (A, B, C, and D) (38 (29) . Also, the dideoxy sequencing method was employed with single-stranded templates subcloned into M13 phage vectors (30, 31) or with restriction fragments subcloned into the Clal site of pBR322 and primed with a pBR322 HindIll primer (no. 1205; New England Biolabs). In vivo and in vitro translation of FMDV polypeptides. In vivo translation products were obtained from infected monolayers of bovine kidney (BK) cells and labeled with radioactive amino acids for 15 or 60 min as previously described (15) . In vitro translation with a rabbit reticulocyte cell-free system prepared by the procedure of Schimke (44) was performed as described previously (15, 34 12 .5% gels in a discontinuous Tris-glycine buffer system (26) . The separated bands were located in the gels by autoradiography and sliced out, and the proteins were eluted electrophoretically (43) . Microsequencing (10, 11) was performed in a Beckman 890B sequencer with 1 mg of apomyoglobin as a carrier. The myoglobin sequence was verified by thin-layer chromatography on a small portion of the sample, and the radioactivity of the remainder was determined by liquid scintillation counting (35) .
RESULTS
Restriction map of the coding region of the FMDV genome. Inserts from selected cDNA clones derived from the FMDV genome after priming with calf thymus DNA, oligodeoxythymidylic acid, and synthetic oligonucleotide primers are depicted in Fig. 1 . Restriction endonuclease analysis, sizing, and comparison to the plasmid insert T465, which contains the genetic information coding for VP1 (22) , were used to position the plasmid inserts within the FMDV genome (Fig. 1) .
Nucleotide and derived amino acid sequences. Sequencing from the 5'-labeled sites (dots on arrows in Fig. 1 ) of restriction fragments of cloned cDNA inserts (middle row of Fig. 1 ) yielded sequences for the coding region of A12 119 FMDV (Fig. 2) . All sequences were confirmed by sequencing from more than one labeling or priming site.
The nucleotide sequence of the A12 FMDV contains a single open reading frame of 6,996 nucleotides (Fig. 2) . The derived amino acid sequence contains recognizable sequences of structural proteins VP4, VP2, VP3, VP1, and VPg and the viral RNA polymerase (12, 22, 36) . The other two reading frames contain multiple stop codons with no potential for translation into proteins larger than 10,000 daltons. In addition, 620 nucleotides were identified 5' of the AUG codon which starts the open reading frame. There are six AUG codons in this 620-nucleotide region; however, before the AUG at nucleotides 621 through 623, termination codons are present in all three reading frames. The nucleotide sequence has not been determined in the region 5 (17) . Microsequencing of this leader polypeptide (Table 1) , isolated in vivo or in vitro, failed to release radioactive methionine or leucine within the first 30 residues (Fig. 3A) . Since acetylation is a common amino-blocking reaction for viral proteins, in vitro translation was performed in the presence of oxaloacetic acid and citrate synthetase to inhibit acetylation (33) . Analysis of P16 synthesized under the above conditions (Fig. 3B) indicated the release of methionine in sequencing cycle 1 and leucine in sequencing cycle 5. However, the derived amino acid sequence in the single open reading frame indicates that sequencing from the first methionine (Fig. 2 , nucleotides 1 through 3) would yield leucine at positions 10 and 22 and methionine at position 29. The second methionine, 84 bases downstream, is followed by a leucine in position 5. Therefore, it would appear likely that translation begins at the second AUG codon in the open reading frame. Additional leucines are encoded at positions 25 and 29, but because of decreased repetitive yield these residues were obscured by a rising background of radioactivity. The methionine and leucine residues positioned the probable start of P16-L at the AUG codon more than 700 nucleotides 3' of the polycytidylic acid tract and 6,912 nucleotides from the UAA termination codon. It should be mentioned that the above information does not allow us to unequivocally state that this AUG codon is the start site of P16-L. Also, if initiation in vitro occurs at an abnormal site that has a sequence of methionine at the first position and leucine at the fifth position, i.e., nucleotide 700, we would not be able to distinguish this from correct initiation. Nevertheless, we conclude that our suggestion is probably correct, because of the significant increase in the release of methionine after inhibition of acetylation, the release of leucine in cycle 5, and the similarity of P16-L polypeptides from in vitro and in vivo demonstrated by tryptic peptide analysis (39) . Furthermore, Beck et al. (3) have also suggested that translation of P16-L begins at the comparable AUG in FMDV serotype Cl, whereas the preceding AUG is recognized as the start of P20a, the major viral protein translated in vitro at high magnesium concentrations (unpublished observations). Our attempts to sequence P20a isolated from high-magnesium in vitro acetylation-inhibited translations were inconclusive. P1 genome region: structural polypeptides. The amino and carboxy termini of the larger viral capsid polypeptides and their precursor cleavage sites have been previously identified (1, 28, 46) (Fig. 2) . Cleavage between P16-L and the smallest capsid polypeptide, VP4, was placed provisionally at positions 609 through 610 between glycine and glutamine for type A10 (6) and at positions 648 through 649 between glycine and asparagine for type Cl (3). Attempts at microsequencing P91 and VPO (Table 1) and amino-terminal dansylation or Edman degradation of purified VP4 failed, indicating that the amino terminus of VP4 is blocked.
Polypeptides generated from the P2 genome region. Microsequencing of the primary cleavage product, P56-2AC (Table 1), of the P2 genome region (17) released leucine from position 14 and methionines from positions 21 and 25 ( Fig. 2  and 4A ). This placed P56-2AC 16 amino acids away from the lysine-glutamine-leucine-leucine C terminus of VP1 and identified an apparent potential cleavage sequence, arginine-proline. To verify the cleavage point, P14-2A (Table 1) was sequenced, releasing leucine from position 14 and methionines from positions 21 and 25 (data not shown), demonstrating that this polypeptide is at the 5' end of the P2 region and confirming the arginine-proline cleavage sequence. Evidence indicates that the other polypeptide coded by the P2 region, P41-2C (17) , is altered in guanidine-resistant mutants of FMDV type 0 (41) . Microsequencing of P41-2C released leucines at positions 1, 13, 19, 22, and 24 ( Fig. 2 and 4B ).
This positioned P41-2C at the 3' end of P2. Thus the P2 region codes for P14-2A (154 amino acids) and P41-2C (318 amino acids), both of which have recently been reported to be associated with membranous fractions of cells (17) .
Polypeptides derived from the P3 genome region. The P3 region encodes the previously identified RNA polymerase (9, 36), a putative viral protease (15, 23) , the three tandem 23-to 24-amino-acid VPg proteins (12) , and an additional polypeptide of unknown function (17) . The genome locations of the three VPg proteins (12) and the RNA polymerase (36) have been reported. Microsequencing of the remaining major polypeptides, P19-3A and P18-3C, from this region revealed P19-3A to be the most 5' of these two proteins. Leucine residues were released at positions 10 and 13, and a methionine was released at position 29 ( Fig. 2 and SA).
Microsequencing of P18-3C released methionine from positions 11 and 13 and leucine from positions 8, 21, and 23 ( Fig.  2 and SB). By analogy to the location of the proteases coded for by FMDV type O1k, poliovirus, and encephalomyocarditis virus, we suggest that P18-3C is the putative FMDV protease. Thus, the order of the proteins in the P3 genome region appears to be P19-3A/VPgl-VPg2-VPg3-3B/P18-3C/P61-3DPoL. DISCUSSION The results in this manuscript present the nucleotide sequence and the complete nucleotide-derived amino acid sequence for the coding region of the FMDV type A12 genome. Similar results for FMDV types Cl and A10 have recently been published (3, 6) . Furthermore, based on microsequencing of polypeptides isolated from infected cells and from a cell-free translation system, we demonstrate the map position of the major functional viral polypeptides and the protease cleavage sites recognized by viral and cellular proteases on the polyprotein.
Upstream of the single open reading frame, we have identified 620 nucleotides that are present at the 3' end of the polycytidylic acid tract. Within the next 87 nucleotides there are two potential AUG codons, and our data indicate that initiation of translation of P16-L probably takes place at the second AUG codon (nucleotides 85 through 87) and that the initiating methionine is acetylated. This codon has features in common with the model proposed by Kozak (24) for efficient initiation of translation (AXX AUG G). The first AUG in the open reading frame has been postulated to be utilized for synthesis of an alternative leader component (P20a-L), which is related to P16-L by immunoprecipitation (3) . Initiation at the site utilized for P20a is not normally very efficient (39) VP4 indicates the uncertain cleavage point. The 16-amino-acid section between VP1 and P14-2AC which was not identified by sequencing of any precursor or product is designated by X?. Reanalysis of the nucleotide sequence has revealed an additional CUG leucine codon at the carboxy terminus of VP1 as compared with the sequence reported previously (22) . and P1 and between P1 and P2 is presumably by a host information demonstrates that the A12 Pl-P2 cleavage ocprotease, some homology at these sites might be expected.
curs between leucine and asparagine and the same potential A consensus sequence deduced from the Pl-P2 junction of L-Pl glycine-asparagine cleavage is present at positions 216 eight FMDV strains was used to suggest that the L-P1
and 217 for type A12. However, based on additional unpubcleavage occurred between glycine and asparagine at amino lished information that type A10 VP4 contains proline (6) (36, 37) as described previously (8); acetate salts were excluded, and the potassium concentration was adjusted to 101 mM when it was desired to inhibit amino-terminal acetylation (B) . In addition, acetylation-inhibited lysates contained 0.15 FLM oxaloacetic acid and 1 U of citrate synthetase (30 Carroll et al. (6) proposed cleavage of L-P1 to occur at a glycine-glutamine pair (amino acids 204 and 205) in type A10. The amino acid sequence through this region (residues -200 through 230) is identical for A12, A10, and Cl. In the absence of definitive amino acid sequencing data, we feel that the L-P1 cleavage cannot be defined at this time, and the data in Fig. 2 and Tables 1, 2 , and 3 reflect this uncertainty. Within the P2 genome region of FMDV, only two products (P14-2A and P41-2C) are generated as compared with three in poliovirus and encephalomyocarditis virus (38) . However, the nucleotide sequence defines a small peptide of 16 amino acids which is not present at the C terminus of VP1 (1, 33) or on the amino terminus of either the P2 genome precursor (P56-2AC) or its most 5' product (P14-2A) (this 16-aminoacid peptide is designated in Fig. 2 by the "X?"). Since translation is contiguous, either rapid proteolytic processing removes these 16 amino acids, or an additional cleavage between an arginine-proline sequence (Table 1) has occurred. Work is currently underway with antiserum against a synthetic peptide corresponding to a portion of "X" to identify the product(s) that may contain this peptide. The identical amino acid sequence is present in A10 (6) and type Cl (3), with the exception of the residues occurring at the arginine-proline cleavage site (A12, proline-arginine-proline; Cl, proline-glycine-proline; and A10, leucine-glycine-proline). Considering this difference, it will be interesting when amino acid sequencing is performed to see whether such a peptide is not found with types A10 and Cl.
The P3 genome region of FMDV is known to code for the previously identified viral RNA polymerase (9, 36) , three tandem VPg molecules (12) , and a viral protease (15, 23) . The relative position of the RNA polymerase and the three tandem VPg molecules has been confirmed, whereas the remaining two components, P19-3A and P18-3C, are the first and third polypeptides translated in this genome region. The poliovirus protease maps in the third position in the P3 genome region (18) . By analogy to these systems, P18-3C may be the FMDV protease. Recently, using an E. coli These experiments reveal that, in contrast to poliovirus and encephalomyocarditis virus proteolytic cleavages, little homology is apparent in cleavage of the FMDV polyprotein. There does appear to be recognition of glutamic acid or glutamine residues followed by glycine, serine, or threonine (Table 1) . This specificity is similar to the glutamine-glycine sequence recognized by the poliovirus and encephalomyocarditis virus proteases (18, 34) . In addition, a second general cleavage sequence is recognized: lysine-glutamineleucine-leucine-/-asparagine, lysine-glutamine-/-leucine, and lysine-glutamine-/-isoleucine. These three related sequences occur on the borders of the P2 genome region and between the two functional proteins (P14-2A and P41-2C) within this genome region. However, present information suggests that these two general cleavage sequences can be recognized by either a virus-or a host-derived protease. Although there are similarities between the specificity of the poliovirus and FMDV proteases, comparison of their amino acid sequences reveals only three limited areas of homology (unpublished observations).
The calculated molecular weights and pKI values of the identified structural and nonstructural proteins of type A12 FMDV are shown in Table 2 . Proteins VP1 and the VPg molecules are highly basic, whereas proteins P14-2A and P41-2C both have long tracts of hydrophobic or uncharged residues as determined by the algorithm of Hopp and Woods (20) , a characteristic that correlates well with their association with membranes (17) . No strongly hydrophobic area was identified 5' adjacent to the VPgs for A12 or A10 (6), as is found with poliovirus (42) . Both show a strongly hydrophobic 16-amino-acid span 77 amino acids 5' of the first VPg about midway in the P19-3A sequence. However, the potential for this region allowing membrane association of a VPg precursor seems unlikely due to preliminary evidence that VPg is processed from a P81 precursor (VPg-C-POL) (17) rather than P19 as has been shown for poliovirus (42) .
A comparison of the complete coding region of FMDV A10 and A12 and the L-P1-P2 regions for A12 and Cl reveals a high degree of amino acid homology among most of the viral polypeptides (Table 3) . As expected, the immunogenic VP1 polypeptide contains regions of high variability between the two subtypes A12 and A10 (about 11% different) and a significantly higher variation between serotypes A12 and Cl (31%). Although the VP4 amino acid sequence is highly conserved in all three types, as are VP2 and VP3 between A12 and A10, VP2 and VP3 show significantly more difference between the two serotypes A12 and Cl (23 and 19%, respectively, for VP2 and VP3). These differences are scattered more broadly in VP2 and especially in VP3 than for VP1 and might suggest a more indirect effect on antigenic differences shown by the two serotype groups. Surprisingly, the nonstructural polypeptide(s) P16-L (P20a-L) shows significant differences in amino acid sequence (Table 3) , even between the two more closely related A subtypes. It is difficult to speculate how the observed degree of variation would effect a presumed single function of the nonstructural leader segments. Another significant difference initially apparent in a nonstructural polypeptide is 13 consecutive amino acid changes in the viral protease (Fig. 2 
